Fintel reports that on March 25, 2025, Maxim Group upgraded their outlook for ... Inc. is a clinical stage pharmaceutical company focused on the development of a broad portfolio of oncology ...

Fintel reports that on April 4, 2025, Maxim Group downgraded their outlook for ... Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic ...

Maxim Global said these costs however, are expected to be offset by the revenue generated from the development of the land. The group said its management team envisages that the development will ...

Maxim Group’s price objective would suggest a ... scPharmaceuticals Inc, a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products.

In a filing with Bursa Malaysia, Maxim said the group acquired the land through ... station within an area designated as a transit-oriented development zone in the Subang Jaya township.

Maxim Group assumed coverage on shares of Nuvectis Pharma (NASDAQ:NVCT – Free Report) in a research note issued to investors on Wednesday morning, MarketBeat reports. The firm issued a buy rating and ...